Parkside Financial Bank & Trust
BankPosition in BTAI — BioXcel Therapeutics, Inc.
CIK 1455267
SAINT LOUIS, MO
Position in BTAI
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$150
-$29 QoQ
Shares Held
112
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 40 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in BTAI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Parkside Financial Bank & Trust holds $711,680 across 30 Drug Manufacturers - Specialty & Generic names. BTAI ranks #29 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
12,038 | $162,632 | |
| 2 | ZTS |
Zoetis Inc.
|
1,074 | $126,956 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
1,147 | $86,999 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
136 | $80,644 | |
| 5 | HLN |
Haleon plc
|
5,178 | $51,831 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,560 | $47,411 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
1,704 | $40,775 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
425 | $21,967 |
All Filings in BTAI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $150 | 112 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $179 | 112 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $286 | 112 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $202 | 112 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $227 | 112 | Shares | Sole | 2025-05-08 | |
| No filing history on record for this holder in this stock. | ||||||